FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Pops Diabetes Care Gets FDA Clearance for Blood Glucose Monitor

Dec. 10, 2018
A A

Pops Diabetes’ Pops! one blood glucose monitoring system has received FDA clearance, and plans to begin commercialization in early 2019.

The device attaches directly to the back of a smartphone and is used by the patient through a coaching app.

The app enables users to review their blood glucose trends and share their data with healthcare professionals and family.

View today's stories